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Self-renewing hematopoietic stem cells (HSCs) 
consist of phenotypically and functionally de-
fined long-term HSCs (LT-HSCs), short-term 
HSCs (ST-HSCs), and multipotent progeni-
tors (MPPs) and can progress into interme-
diate lineage-committed progenitors, including 
common lymphoid progenitors (CLPs) and com-
mon myeloid progenitors (CMPs; Weissman, 
2000; Adolfsson et al., 2001; Christensen and 
Weissman, 2001). CLPs differentiate into early 
lymphoid progenitors that give rise to mature 
NK, T, and B cells. CMPs differentiate into 
granulocyte/monocyte progenitors (GMPs) 
that  give  rise  to  mature  granulocytes  and 
monocytes, and into megakaryocyte/eryth-
rocyte progenitors (MEPs) that give rise to 
mature platelets and red blood cells (Weissman, 
2000; Adolfsson et al., 2001; Christensen and 
Weissman, 2001). HSCs establish a balance 
between the self-renewal and hematopoietic 
differentiation,  and  the  balance  is  strictly 
controlled  by  both  extrinsic  and  intrinsic 
mechanisms (Weissman, 2000). Many cytokines, 
including stem cell factor (SCF), thrombopoi-
etin, flt-2 and flt-3 ligands, IL-3, and IL-6, are 
involved in the regulation of HSC self-renewal 
and differentiation (Bodine et al., 1989; Broudy, 
1997; Kimura et al., 1998; Metcalf, 1998). In 
addition, cell apoptosis plays an important role 
in regulating homeostasis of HSCs and their 
commitment and differentiation into distinct 
mature blood cells (Domen et al., 2000; Kondo 
et al., 2003). The Bcl-2 family of proteins is   
a key regulator of cell apoptosis. The BH3   
domain–only proapoptotic Bcl-2 family mem-
bers activate the multidomain death effector 
proteins Bax and Bak, which promote apop-
tosis by perturbing the permeability of the 
endoplasmic reticulum and mitochondrial outer 
membrane, whereas antiapoptotic Bcl-2 fam-
ily members can sequester the BH3 domain–
only members, preventing activation of Bax 
and Bak (Cheng et al., 2001; Wei et al., 2001; 
Scorrano et al., 2003). The antiapoptotic Bcl-2 
family member Mcl-1 plays a specific role   
in the homeostasis of HSCs and other hema-
topoietic progenitors. Inducible deletion of   
Mcl-1 in mice results in the loss of HSCs and 
other hematopoietic progenitors (Opferman   
et al., 2005).
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Mice and rats lacking the guanosine nucleotide-binding protein Gimap5 exhibit peripheral T cell 
lymphopenia, and Gimap5 can bind to Bcl-2. We show that Gimap5-deficient mice showed 
progressive multilineage failure of bone marrow and hematopoiesis. Compared with wild-type 
counterparts, Gimap5-deficient mice contained more hematopoietic stem cells (HSCs) but fewer 
lineage-committed hematopoietic progenitors. The reduction of progenitors and differentiated 
cells in Gimap5-deficient mice resulted in a loss of HSC quiescence. Gimap5-deficient HSCs and 
progenitors underwent more apoptosis and exhibited defective long-term repopulation capacity. 
Absence of Gimap5 disrupted interaction between Mcl-1—which is essential for HSC survival—
and HSC70, enhanced Mcl-1 degradation, and compromised mitochondrial integrity in progenitor 
cells. Thus, Gimap5 is an important stabilizer of mouse hematopoietic progenitor cell survival.
© 2011 Chen et al.  This article is distributed under the terms of an Attribution–
Noncommercial–Share Alike–No Mirror Sites license for the first six months after 
the publication date (see http://www.rupress.org/terms). After six months it is 
available under a Creative Commons License (Attribution–Noncommercial–Share 
Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/
by-nc-sa/3.0/).
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mice had more pronounced deficiency in lymphoid than 
myeloid lineages (Fig. 1 B). Within the B cell lineage, pro/
pre–B progenitors (B220+IgM) were markedly reduced, 
and  immature  (B220+IgM+)  and  mature  (B220hiIgM+)   
B cells were nearly absent in Gimap5-deficient mice (Fig. 1, 
D and E). Similarly, more mature myeloid (Mac-1+Gr-1hi) 
and erythroid (Ter119+CD71lo) cells were more severely 
affected than their respective precursors, i.e., Mac-1+Gr-1lo 
and Ter119+CD71+ cells (Fig. 1, F–I). These data show that 
Gimap5 deficiency leads to reduced production of multi-
ple hematopoietic lineages, that the defect is more severe 
in lymphoid than myeloid differentiation, and that it is 
more severe in more mature stages of differentiation in   
either lineage.
Gimap  (GTPase  of  the  immune-associated  protein) 
genes, also known as IAN (immune-associated nucleotide-
binding protein), constitute a family of seven (human and 
rat) or eight (mouse) guanosine nucleotide-binding proteins 
clustered in a small syntenic genomic region of human 
chromosome 7, rat chromosome 4, and mouse chromosome 6, 
respectively  (Poirier  et  al.,  1999;  Dahéron  et  al.,  2001; 
MacMurray  et  al.,  2002;  Stamm  et  al.,  2002). A  loss  of   
Gimap5 function is the cause of T cell lymphopenia in rats as a 
result of a near complete loss of postthymic peripheral CD8 
T cells and triggers a lethal autoimmune disease in the pres-
ence of the diabetogenic MHC locus Iddm1 (Plamondon   
et al., 1990; Groen et al., 1995; Iwakoshi et al., 1998; Hornum 
et al., 2002; MacMurray et al., 2002; Pandarpurkar et al., 
2003; Michalkiewicz et al., 2004). Human Gimap5 has been 
shown to inhibit cell apoptosis induced by either okadaic 
acid or  radiation (Sandal et al., 2003). No loss-of-function 
mutations  have  been  described  in  human  patients,  but  a 
polymorphism in the polyadenylation signal sequence of the 
human Gimap5 gene that reduces the abundance of prop-
erly terminated transcripts appears to be associated with the 
presence of islet autoantibodies in type 1 diabetes patients 
and with an increased risk of systemic lupus erythematosus 
(Hellquist et al., 2007; Shin et al., 2007). Gimap5 gene abla-
tion in the mouse does not elicit spontaneous autoimmune 
disease but impairs the survival of peripheral T cells and of 
NKT cells, replicating the phenotype of the Gimap5-deficient 
rat (Schulteis et al., 2008). Moreover, a Gimap5-deficient 
mouse exhibits a marked reduction in the abundance of 
NK and B cells, mild thrombocytopenia, altered erythrocyte 
morphology, excessive extramedullary hematopoiesis in the 
liver, and a limited life-span of mutant mice of 15 wk 
(Schulteis et al., 2008; Barnes et al., 2010). These observa-
tions strongly suggest that the biological function of Gimap5 
in the mouse might extend beyond controlling the survival   
of peripheral CD8 T cells. In this paper, we show that   
Gimap5-deficient mice indeed exhibit a progressive loss of 
multilineage hematopoietic capacity that can be traced to 
defective function of HSCs and early progenitor populations 
in the BM, and that these defects are associated with a dis-
ruption of mitochondrial chaperon function of HSC70 for 
the apoptosis regulator Mcl-1.
RESULTS
Gimap5 deficiency causes progressive bone marrow failure
In contrast with younger animals, whole BM cellularity 
was dramatically reduced in 9–14-wk-old Gimap5-deficient 
mice as compared with age- and sex-matched littermates 
(Fig. 1 A). Diminished absolute cell numbers were observed 
in lymphoid (Thy1.2+ or B220+), myeloid (Mac-1+Gr-1+), 
and erythroid (Ter119+) BM subpopulations (Fig. 1 B). It is 
of note that the body weight of Gimap5-deficient mice was 
only  slightly  reduced  compared  with  control  wild-type 
mice (Fig. 1 C), which is unlikely to account for the dra-
matic reduction in the number of total BM cells and hema-
topoietic cells in the mutant mice. In addition, the mutant 
Figure 1.  Impaired development of multiple hematopoietic  
lineages in Gimap5-deficient mice. (A) Bar graphs show the numbers 
of total BM cells in wild-type (+/+) and Gimap5-deficient (/) mice.  
(B) Bar graphs show the numbers of lymphoid (B220+and Thy1.2+), my-
eloid (Mac-1+Gr-1+), and erythroid (Ter119+) linage cells in BM of wild-
type and Gimap5-deficient mice. (C) Body weight of 9–14-wk-old 
wild-type or Gimap5-deficient mice was measured. (D–I) Pro/pre–,  
immature, and mature B cells (D and E), immature and mature myeloid 
cells (F and G), and erythroid cells at different maturation stages (H and I) 
in the BM of Gimap5-deficient and wild-type mice. BM cells from wild-
type or Gimap5-deficient mice were stained with anti-B220 and anti-IgM, 
anti–Mac-1 and anti–Gr-1, or anti-Ter119 and anti-CD71. The percentages 
(D, F, and H) and numbers (E, G, and I) of the indicated cells in total living 
BM cells are shown. Data shown are obtained from or representative of  
9 (A, B, and D–I) or 14 (C) mice of each genotype. Error bars show ±SD.  
*, P < 0.001; **, P < 0.05.JEM VOL. 208, May 9, 2011 
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Gimap5 is expressed in hematopoietic progenitors
Measurement of Gimap5 mRNA by real-time quantitative 
PCR in BM subpopulations showed that Gimap5 mRNA 
was present not only in T and B cells, as reported previously 
(Nitta et al., 2006), but was also readily detectable in sorted 
LSK, LK, HSC, MPP, CLP, CMP, GMP, and MEP and distinct 
Gimap5 deficiency differentially affects HSCs  
and progenitors
The effect of Gimap5 deficiency on multiple hematopoietic 
lineages indicated that the defect might arise from the stem 
cell and/or primitive progenitor compartment. FACS analysis 
of the BM from 9–14-wk-old animals demonstrated that the 
relative abundance of the LinIL7Rc-Kit+Sca1+ (LSK) pop-
ulation in BM was increased approximately threefold, whereas 
their absolute numbers were comparable to those in wild-
type mice (Fig. 2, A and B). In contrast, although the relative 
abundance of the LinIL7Rc-Kit+Sca1 (LK) population 
was comparable to that of wild-type littermates, the absolute 
number of LK cells was reduced between two- and threefold 
(Fig. 2, A and B). Among the LSK population comprising   
LT-HSC (CD34CD135), ST-HSC (CD34+CD135), and 
MPP (CD34+CD135+), both the relative and absolute abun-
dance of LT-HSCs and ST-HSCs was increased, whereas the 
reverse was observed for MPP (Fig. 2, C and D). Hence, 
Gimap5-deficient BM contains approximately twice as many 
ST- and LT-HSC as wild-type marrow, which is balanced by 
a corresponding reduction in the absolute number of MPP to 
yield an apparent normal absolute number of the LSK com-
partment in the BM of Gimap5-deficient mice.
Analysis of the LK subpopulations revealed that the relative 
abundance of CMPs (CD34+FcRlo), GMPs (CD34+FcRhi), 
and MEPs (CD34FcRlo) was similar, whereas the absolute 
numbers of these populations were markedly reduced in the 
BM of Gimap5-deficient relative to wild-type mice (Fig. 2,   
E and F). Similarly, although the relative representation of CLPs 
(LinIL7R+Sca1medc-Kitmed) was normal, the absolute num-
bers of this population were reduced in the BM of Gimap5-
deficient relative to wild-type mice (Fig. 2, G and H).
Consistent with this phenotypic analysis, Gimap5-deficient 
BM cells exhibited a substantially diminished capacity for   
cytokine-driven ex vivo colony formation in semisolid growth 
medium. In the presence of IL-3 plus Epo or IL-3 alone, the 
mixed CFUs (CFU-mix) were markedly reduced in BM 
cells from Gimap5-deficient mice relative to wild-type mice 
(Fig. 3 A). The numbers of mixed colonies formed in response 
to SCF and macrophage colonies in response to M-CSF were 
also markedly reduced in the mutant mice (Fig. 3 A). In addi-
tion, the numbers of colonies formed in response to the com-
bination of IL-3, IL-6, and SCF were markedly reduced in 
the mutant mice (Fig. 3 A). It is of note that the total BM cell 
number and the absolute number of progenitors, including 
MPP and other more differentiated progenitors, were both 
markedly reduced in Gimap5-deficient relative to wild-type 
mice (Figs. 1 and 2). However, proportions of many types of 
hematopoietic progenitors (e.g., MEP) were not reduced in 
the BM of Gimap5-deficient relative to wild-type mice (Fig. 2). 
The number of many types of hematopoietic progenitors should 
be similar within a same quantity of Gimap5-deficient and 
wild-type BM cells. Thus, marked reduction in the number of 
colonies formed by a same quantity of Gimap5-deficient relative 
to wild-type BM cells suggested that colony production per 
progenitor cell is likely impaired in the absence of Gimap5.
Figure 2.  Increased numbers of HSCs and markedly reduced num-
bers of primitive hematopoietic progenitors in Gimap5-deficient 
mice. (A) LSK and LK populations in Gimap5-deficient mice. BM cells from 
wild-type or Gimap5-deficient mice were stained with anti-lineage cock-
tail (Mac-1, Gr-1, B220, CD4, CD8, and Ter-119), IL-7R, c-Kit, and Sca-1 
antibodies. The percentages indicate LSK and LK cells in a gated 
DAPIlinIL7R population. (B) Bar graphs show the numbers of LSK and 
LK in BM of wild-type and Gimap5-deficient mice. (C) LT-SHC, ST-SHC, 
and MPP populations in Gimap5-deficient mice. BM cells from wild-type 
or Gimap5-deficient mice were stained with anti-lineage cocktail (Mac-1, 
Gr-1, B220, CD4, CD8, and Ter-119), IL7R, c-Kit, Sca-1, CD34, and CD135 
antibodies. The percentages indicate LT-HSC (CD34CD135), ST-HSC 
(CD34+CD135), and MPP (CD34+CD135+) in the gated LSK population.  
(D) Bar graphs show the numbers of LT-HSC, ST-HSC, and MPP in the BM 
of wild-type and Gimap5-deficient mice. (E) CMP, GMP, and MEP popula-
tions in Gimap5-deficient mice. BM cells from wild-type or Gimap5- 
deficient mice were stained with anti-lineage cocktail (Mac-1, Gr-1, B220, 
CD4, CD8, Ter-119, and IL7R), c-Kit, Sca-1, CD34, and FcR antibodies. The 
percentages indicate CMP, GMP, and MEP in the gated LK population.  
(F) Bar graphs show the numbers of CMP, GMP, and MEP cells in BM of 
wild-type and Gimap5-deficient mice. (G) CLP population in Gimap5-
deficient mice. BM cells from wild-type or Gimap5-deficient mice were 
stained with anti-lineage cocktail (Mac-1, Gr-1, B220, CD4, CD8, and Ter-119), 
IL-7R, c-Kit, and Sca-1 antibodies. The percentages indicate CLP in the 
gated DAPIlinIL7R+ population. (H) Bar graphs show the numbers of 
CLP in BM of wild-type and Gimap5-deficient mice. Data shown are ob-
tained from or representative of nine (A, B, G, and H) or seven  
(C–F) mice of each genotype. Error bars show ±SD. *, P < 0.001; **, P < 0.05.926 Gimap5 in HSC survival and quiescence | Chen et al.
erythroid cells, displayed CD45.2 origin (Fig. 3 C). The im-
paired engrafting capacity of Gimap5-deficient hematopoi-
etic progenitors was further confirmed in the competitive 
repopulation experiments 16 wk after BM transplantation 
(Fig. S1). It is of note that no significant differences in BM 
homing between Gimap5-deficient and wild-type hemato-
poietic progenitors were observed (Fig. 3 D).
In the Gimap5-deficient rat, occurrence of autoimmunity 
is strictly dependent on coinheritance of the appropriate 
(diabetogenic) MHC locus (Ono et al., 1988; Hanenberg et al., 
1989; Huang et al., 1994). In the F344 rat lacking this particu-
lar MHC, no autoimmunity occurs (Fuller et al., 2006). In 
addition, Gimap5-null mice with a C57 or BALB/c back-
ground do not develop spontaneous autoimmunity (Schulteis 
et al., 2008). Gimap5 deficiency–caused autoimmunity is as-
sociated with reduction of regulatory T cells (T reg cells; 
Poussier et al., 2005; Hillebrands et al., 2006). To further rule 
out that the impairment of repopulation ability of Gimap5-
deficient BM is a result of autoimmune attack, we examined 
T reg cell population and lymphocyte activation status in 
competitively reconstituted recipients. Recipients that re-
ceived an equal number of Gimap5-deficient (CD45.2) and 
wild-type competitor BM cells (CD45.1) possessed a normal 
population of T reg cells, although these T reg cells were de-
rived from wild-type but not Gimap5-deficient BM (Fig. S2 A). 
Control recipients that received equal numbers of CD45.2 
and CD45.1 wild-type BM cells also had a normal popula-
tion of T reg cells derived from both types of wild-type BM 
cells (Fig. S2 A). Consistent with the observation of normal   
T reg cell populations in both types of recipients, T and B cells 
from these recipients barely showed expression of activation 
lineages of hematopoietic BM cells, including NK (NK1.1+), 
B (B220+), T (Thy1.2+), myeloid (Mac-1+), and erythroid 
(Ter119+) lineages (Fig. 3 B). Overall, the amounts of Gimap5 
mRNA were slightly higher in lymphoid lineages than in 
myeloid lineages (Fig. 3 B). Thus, the cellular distribution of 
Gimap5 mRNA in the BM correlated with the range of cell 
subpopulations affected by Gimap5 deficiency.
Gimap5 deficiency impairs hematopoietic progenitor 
repopulation ability
To determine whether there is an intrinsic defect in the 
long-term repopulation capacity of Gimap5-deficient HSC, 
competitive repopulation experiments were performed. As 
determined  8  wk  after  transfer  of  an  equal  number  of   
Gimap5-deficient (CD45.2) and wild-type competitor BM 
cells (CD45.1) into lethally irradiated wild-type CD45.1 con-
genic mice, markedly <50% of the total BM cells were de-
rived from Gimap5-deficient donor cells (Fig. 3 C). This 
deficit was not limited to LK and CLP progenitors, myeloid 
cells (Mac-1+ or Gr-1+), lymphoid cells (B220+, Thy1.2+, or 
NK1.1+), and erythroid cells (Ter119+) but was also evident 
in the LSK compartment, including HSCs and MPPs. A 
corresponding underrepresentation of Gimap5-deficient cells 
was observed in the spleen of competitively repopulated recipi-
ents, including myeloid (Mac-1+ or Gr-1+), lymphoid (B220+, 
Thy1.2+, or NK1.1+), and erythroid (Ter119+) cells (Fig. 3 C). 
In contrast, in recipients that received equal numbers of 
CD45.2 wild-type and CD45.1 wild-type competitor BM 
cells, 50% of total BM cells, including LSK/LK, HSC, MPP, 
and CLP progenitors, myeloid, lymphoid, and erythroid 
cells, and total splenic cells, including myeloid, lymphoid, and 
Figure 3.  Reduced colony formation 
ability and impaired engrafting capacity 
of Gimap5-deficient hematopoietic pro-
genitors. (A) BM cells from wild-type and 
Gimap5-deficient mice were plated in dupli-
cate or triplicate with the indicated cytokines, 
and colonies were scored at day 4 (for Epo + 
IL3), day 6 (for IL3 + IL6 + SCF), and day 12 
(for the rest). Data shown are representative 
of three distinct experiments. *, P < 0.01.  
(B) The indicated cells were sorted from BM of 
wild-type mice. Total RNA was isolated from 
the cells and subjected to real-time RT-PCR 
analysis of Gimap5 gene expression in tripli-
cate. Levels of Gimap5 transcription were 
presented as copies of Gimap5 transcripts per 
Actin transcript. Data shown are obtained 
from two independent experiments. (C) BM 
cells from wild-type (CD45.2+) or Gimap5-
deficient mice (CD45.2+) were mixed 1:1 with 
wild-type competitor BM cells from B6 SJL 
mice (CD45.1+) and transplanted into lethally 
irradiated B6 SJL mice. 8 wk after BM transplantation, the recipient mice were analyzed for the relative contribution of donor engraftment. Data shown 
are representative of five recipients per donor group. (D) BM cells from CD45.2+ wild-type or Gimap5-deficient mice were transplanted into lethally irradi-
ated CD45.1+ B6 SJL mice. 6 h later, the percentages of CD45.2+Lin donor hematopoietic progenitors in recipient BM were determined by FACS. Data 
shown are representative of four transplantations for each donor genotype. Error bars show ±SD.JEM VOL. 208, May 9, 2011 
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Gimap5 stabilizes Mcl-1 by strengthening the association  
of Mcl-1 with HSC70
To  understand  the  molecular  mechanism  underlining  the 
regulation of hematopoietic progenitor apoptosis by Gimap5, 
we sought to identify molecules capable of interacting with 
Gimap5. Bcl-2 family members are important regulators of 
cell survival/apoptosis and each member plays a specific role 
markers, such as CD69, CD80, or CD86 (Fig. S2, B and C). 
Thus, in the absence of immune activation, Gimap5-deficient 
BM cells display a reduced ability to competitively repopulate. 
These outcomes document that Gimap5 deficiency in a cell-
autonomous manner impairs the ability of BM resident cells 
to competitively repopulate virtually all hematopoietic lineages, 
consistent with a defect in HSC and/or early progenitors.
Gimap5 sustains HSC quiescence and survival
To characterize the role of Gimap5 for HSC function, the   
effect of Gimap5 deficiency on in vivo proliferation and 
survival of HSC was examined by measuring in vivo BrdU 
incorporation  and  Annexin V/DAPI  staining,  respectively. 
The fraction of BrdU+ HSC-enriched LSK cells in Gimap5-
deficient mice was more than twofold higher than that in 
wild-type counterparts (Fig. 4, A and B). Within the LSK 
compartment, 20% of Gimap5-deficient HSC had incor-
porated BrdU, compared with 2% of wild-type HSC. The 
increased BrdU incorporation in Gimap5-deficient MPP was 
slightly less pronounced (Fig. 4, A and B). Conversely, the 
fraction of more differentiated BrdU+ Gimap5-deficient LK 
cells was only slightly elevated when compared with that of 
corresponding wild-type cells (Fig. 4, A and B). RNA and 
DNA content analysis by Pyronin Y and DAPI staining 
further  revealed  that  the  proportions  of  Gimap5-deficient 
CD135 LSK cells (LT- and ST-HSC) and CD150+ LSK cells 
(LT-HSC) in the S + G2/M phases were markedly increased 
when compared with those of wild-type controls (Fig. 4 C). 
In addition, Annexin V/DAPI staining revealed that the rela-
tive abundance of apoptotic LSK cells was markedly higher 
in Gimap5-deficient relative to wild-type mice (Fig. 4 D). 
Consistent with earlier findings in T cell line (Nitta et al., 
2006), increased apoptosis was also noted in more differenti-
ated or committed hematopoietic cells, including B cells at 
different developmental stages (unpublished data). Furthermore, 
a marked increase of apoptosis was also observed in the Gimap5-
deficient CD135 LSK population, comprising LT- and ST-
HSC (Fig. 4 E). These data demonstrate that the loss of Gimap5 
function not only causes apoptosis of hematopoietic stem and 
progenitor cells but also triggers a marked loss of HSC quies-
cence. The overall preponderance of the proliferative effect of 
Gimap5 deficiency in stem cells is consistent with, and explains, 
the increased absolute number of these cells (Fig. 2, C and D).
The loss of HSC quiescence in Gimap5-deficient mice 
could be caused by a reduction in numbers of hematopoietic 
progenitors and differentiated cells in these mutant mice. To 
test this possibility, cell proliferation of Gimap5-deficient HSC 
was examined in competitively reconstituted recipients that had 
normal numbers of all hematopoietic lineages derived from 
wild-type CD45.1 BM (Fig. 3 C). It is of note that CD45.2+ 
Gimap5-deficient HSC in competitively reconstituted recipi-
ents displayed comparable BrdU incorporation relative to 
CD45.2+ wild-type HSC in control recipients (Fig. 4 F). 
Thus, the loss of quiescence in HSCs in Gimap5-deficient 
mice is the result of an apoptosis-caused reduction in num-
bers of hematopoietic progenitors and differentiated cells.
Figure 4.  Loss of quiescence of Gimap5-deficient HSCs and in-
creased apoptosis of Gimap5-deficient LSK progenitors. (A) BrdU was 
injected into wild-type and Gimap5-deficient mice. 2 h later, BM cells 
were isolated from the mice and stained with anti-lineage cocktail (Mac-1, 
Gr-1, B220, CD4, CD8, and Ter-119), c-Kit, Sca-1, and CD135 antibodies, 
followed by BrdU and DAPI staining. The percentages indicate BrdU+ cells 
in gated LSK, LK, HSC, and MPP populations. (B) Statistical analysis of the 
percentages of BrdU+ cells from panel A. (C) BM cells from indicated mice 
were stained with anti-lineage cocktail, c-Kit, Sca-1, and CD135 or CD150 
antibodies, followed by Pyronin Y and DAPI staining. The percentages of 
CD135 LSK cells and CD150+ LSK cells in the G0, G1, and S + G2/M 
phases are shown. (D and E) BM cells from wild-type or Gimap5-deficient 
mice were stained with lineage cocktail, IL-7R, c-Kit, Sca-1, and CD135 
antibodies, followed by Annexin V and DAPI staining. The percentages 
indicate apoptotic Annexin V+DAPI cells in LSK population (D) and in 
CD135 LSK population (HSCs; E). (F) CD45.1+ B6 SJL recipients were 
transplanted with CD45.2+ wild-type (Gimap5+/+) or CD45.2+ Gimap5-
deficient (Gimap5/) BM mixed 1:1 with wild-type competitor BM cells 
from B6 SJL mice as described in Fig. 3 C. 8 wk after BM transplantation, 
BrdU was injected into competitively reconstituted mice. 2 h later, the 
percentages of BrdU+ cells in CD45.2+CD135 LSK population were deter-
mined by FACS. Data shown are representative of or obtained from three 
(A, B, and E), two (C and F), or five (D) mice of each genotype. Error bars 
show ±SD. *, P < 0.001; **, P < 0.05.928 Gimap5 in HSC survival and quiescence | Chen et al.
of proteins. The interaction of Gimap5 with endogenous 
HSC70 was confirmed by coimmunoprecipitation/Western 
blot analysis with specific anti-HSC70 (Fig. 5 A).
Immunoprecipitation of endogenous Mcl-1 or Bcl-xL   
resulted in reciprocal coimmunoprecipitation of Flag-tagged 
Gimap5 (Fig. 5 C), confirming the interaction between Gimap5 
and Mcl-1 as well as Bcl-xL. Immunoprecipitation of endog-
enous HSC70 also resulted in reciprocal coimmunoprecipi-
tation of Flag-tagged Gimap5 (Fig. 5 D), confirming the 
interaction between Gimap5 and HSC70. Moreover, immuno-
precipitation  of  endogenous  Mcl-1  or  Bcl-xL  resulted   
in coimmunoprecipitation of HSC70 (Fig. 5 C), whereas   
immunoprecipitation of endogenous HSC70 resulted in recip-
rocal  coimmunoprecipitation  of  endogenous  Mcl-1  and 
Bcl-xL  (Fig.  5  D),  demonstrating  the  interaction  between 
Mcl-1 or Bcl-xL and HSC70. Therefore, these coimmuno-
precipitation and reciprocal coimmunoprecipitation data 
show that Gimap5, HSC70, and Mcl-1 or Bcl-xL interact 
with each other, demonstrating that these three types of pro-
teins form a ternary protein complex.
Furthermore,  subcellular  fractionation  of  70Z/3  cells 
demonstrated that Flag-tagged Gimap5 localized preferen-
tially in mitochondria-rich fraction (Fig. 5 E), consistent 
with previous finding that endogenous Gimap5 localizes 
on  mitochondria  (Keita  et  al.,  2007).  Mcl-1  localized   
in hematopoiesis. Mcl-1 and Bcl-xL, but not Bcl-2, are im-
portant for the survival of HSCs or other early hematopoietic 
progenitors (Veis et al., 1993; Ma et al., 1995; Motoyama et al., 
1995, 1999; Opferman et al., 2005). A previous study has shown 
that Gimap5 interacts with Bcl-2 in T cell line (Nitta et al., 
2006). Thus, we investigated whether Gimap5 interacted with 
Mcl-1 and Bcl-xL. We engineered the pre–B cell line 70Z/3 
to stably express Flag-tagged Gimap5. The cell lysate was im-
munoprecipitated with anti-Flag, and the immune complex 
was subjected to SDS-PAGE/Western blot analysis for Bcl-2 
family members. Gimap5 interacted with Mcl-1 and Bcl-xL, 
but not Bax or Bad, in pre–B cell line (Fig. 5 A). In addition, 
Gimap5 associated with Bcl-2 in pre–B cell line as previously 
reported in T cells (Nitta et al., 2006; unpublished data).
To identify additional molecules capable of interacting 
with Gimap5, the Flag-tagged Gimap5 immune complex was 
subjected to SDS-PAGE and Coomassie blue staining. A pro-
tein migrating at an apparent molecular mass of 70 kD was 
specifically coimmunoprecipitated with Flag-tagged Gimap5 
(Fig. 5 B). After an in-gel tryptic digestion, the peptides de-
rived from the 70-kD protein were subjected to matrix-assisted 
laser desorption/ionization time-of-flight (MALDI-TOF) 
mass spectrometry analysis (Clauser et al., 1999). The resulting 
mass spectrometry data identified the 70-kD proteins as 
HSC70, a member of the heat shock protein 70 (Hsp70) family 
Figure 5.  A ternary protein complex 
comprised of Gimap5, HSC70, and Mcl-1 
or Bcl-xL. (A) Cell lysates from parental 
70Z/3 cells (parental) or 70Z/3 cells that stably 
express Flag-tagged Gimap5 (Gimap5nFL) 
were incubated with Sepharose beads conju-
gated with anti-Flag. The immune complex 
was subjected to Western blot analysis with 
the indicated antibodies. (B) Cell lysates from 
parental or Gimap5nFL 70Z/3 cells were incu-
bated with Sepharose beads conjugated with 
anti-Flag. The immune complex was subjected 
to SDS-PAGE and Coomassie blue staining. 
Proteins specifically immunoprecipitated with 
anti-Flag in cell lysates derived from Gimap-
5nFL 70Z/3 cells, but not parental 70Z/3 cells, 
were subjected to an in-gel tryptic digestion. 
The peptides derived from the proteins were 
subjected to MALDI-TOF mass spectrometry 
analysis. (C) Cell lysates from parental or  
Gimap5nFL 70Z/3 cells were immunoprecipi-
tated with anti–Mcl-1 or anti–Bcl-xL or  
control IgG. The immune complex was sub-
jected to Western blot analysis with the indi-
cated antibodies. (D) Cell lysates from parental 
or Gimap5nFL 70Z/3 cells were immuno-
precipitated with anti-HSC70. The immune com-
plex was subjected to Western blot analysis 
with the indicated antibodies. (E) The cytosol 
and mitochondria fractions were extracted 
from parental or Gimap5nFL 70Z/3 cells and subjected to Western blot analysis with the indicated antibodies. Tom20 was used as a marker of mitochon-
dria fraction. (F) Gimap5nFL 70Z/3 cells were applied to glass slides and subjected to immunofluoresence analyses with anti-Flag (green) with a combina-
tion of anti–Mcl-1 or anti-HSC70 (red). Data shown are representative of three (A and E) or two (C, D, and F) independent experiments.JEM VOL. 208, May 9, 2011 
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that Gimap5, HSC70, and Mcl-1 form a ternary protein 
complex on mitochondria.
Deletion of the Gimap5 gene abolished Gimap5 protein 
expression (Fig. 6 A), and we examined the effect of Gimap5 
deficiency on the interaction between HSC70 and Mcl-1/
Bcl-xL. Immunoprecipitation of endogenous Mcl-1 or Bcl-xL 
resulted in coimmunoprecipitation of endogenous HSC70 
in wild-type BM-derived B cell progenitors (Fig. 6 B). However, 
in the absence of Gimap5, the amount of endogenous HSC70 
that was coimmunoprecipitated with endogenous Mcl-1 
or Bcl-xL was dramatically reduced (Fig. 6 B). In addition,   
preferentially in mitochondria-rich fraction, whereas Bcl-xL 
localized  in  both  cytosolic  and  mitochondria-rich  frac-
tions (Fig. 5 E), as expected from previous studies (Yang   
et al., 1995; Kaufmann et al., 2003). Although the majority 
of HSC70 localized in cytosolic fraction, it also localized in 
mitochondria-rich fraction (Fig. 5 E). In addition, immuno-
fluorescence and confocal microscopy analysis demonstrated 
that Flag-tagged Gimap5 was able to colocalize with Mcl-1 
and HSC70 on mitochondria (Fig. 5 F), indicating that 
Gimap5, Mcl-1, and HSC70 interact with each other on 
mitochondria. Collectively, these data further demonstrate 
Figure 6.  Requirement of Gimap5 for the asso-
ciation of Mcl-1 with HSC70, Mcl-1 stability, 
mitochondria integrity, and the survival of BM-
derived B cell and hematopoietic progenitors.  
(A) Total cell lysates from IL-7 BM culture–derived 
wild-type or Gimap5-deficient B cell progenitors were 
subjected to Western blot analysis with anti-Gimap5 
or anti-Actin. (B) Cell lysates from wild-type or  
Gimap5-deficient IL-7 BM culture–derived B cell pro-
genitors were immunoprecipitated with anti–Mcl-1 or 
anti–Bcl-xL, followed by Western blot analysis with 
anti-HSC70. (C and D) The cytosol and mitochondrial 
fractions were extracted from IL-7 BM culture– 
derived wild-type or Gimap5-deficient B cell progenitors 
(C) or IL-3 + IL-6 + SCF BM culture–derived wild-type 
or Gimap5-deficient CD34+ hematopoietic progenitors 
(D). These fractions were subjected to Western blot 
analysis with the indicated antibodies. Tom20 was 
used as a marker of mitochondrial fraction. *, nonspe-
cific bands. (E and F) IL-7 BM culture–derived wild-
type or Gimap5-deficient B cell progenitors (E) or 
purified IL-3 + IL-6 + SCF BM culture–derived wild-
type or Gimap5-deficient CD34+ hematopoietic pro-
genitors (F) were cultured without cytokines for the 
indicated times. The total cell lysates were subjected 
to Western blot analysis with the indicated antibodies. 
Data shown are representative of five independent 
experiments. (G) IL-3 + IL-6 + SCF BM culture–derived 
wild-type and Gimap5-deficient CD34+ hematopoietic 
progenitors were cultured in the presence or absence 
of IL-3 + IL-6 + SCF for 16 h, followed by incubation 
with m indicator JC-1. The green (FITC) and red (PE) 
fluorescence were measured by flow cytometry. The 
percentages of cells with decreased mitochondrial 
m in total alive cells are shown. Data shown are 
representative of two independent experiments.  
(H and I) IL-7 BM culture–derived wild-type or Gimap5-
deficient B cell progenitors (H) or IL-3 + IL-6 + SCF 
BM culture–derived wild-type and Gimap5-deficient 
hematopoietic progenitors (I) were cultured in the 
presence of BrdU for 1 h, followed by BrdU and  
7-AAD or DAPI staining. The percentages of BrdU+ cells 
in S/G2/M phase are shown. Data shown are represen-
tative of three (H) or two (I) independent experiments. 
(J and K) IL-7 BM culture–derived wild-type or  
Gimap5-deficient B cell progenitors (J) or IL-3 + IL-6 + SCF BM culture–derived wild-type and Gimap5-deficient hematopoietic progenitors (K) were cultured  
in the absence of cytokines for the indicated times. The cell apoptosis was examined by Annexin V and 7-AAD staining. The percentages indicate cells  
in total (J) or Linc-Kit+Sca+ population (K). Data shown are representative of three independent experiments.930 Gimap5 in HSC survival and quiescence | Chen et al.
The Bcl-2 family, including Mcl-1, is essential for main-
taining mitochondria integrity (Gross et al., 1999; Kuwana   
et al., 2005). Thus, we examined the effect of Gimap5 defi-
ciency on the integrity of mitochondria. The mitochondrial 
potential (m) is an indicator for mitochondria integrity and 
can be assessed by the potential sensing dye JC-1 (Smiley 
et al., 1991; Harris and Thompson, 2000). JC-1 accumulates 
within the intact mitochondria as bright red J-aggregates but 
remains in the cytoplasm as a green fluorescent monomer 
when mitochondria lose m (Smiley et al., 1991). A greater 
number of Gimap5-deficient BM-derived primary B cell 
progenitors displayed a decrease of mitochondrial m com-
pared with corresponding wild-type B progenitors (unpub-
lished data). Similarly, a larger proportion of Gimap5-deficient 
BM-derived hematopoietic progenitors displayed a decrease 
of mitochondrial m compared with corresponding wild-
type progenitors after cytokine withdrawal (Fig. 6 G). Thus, 
Gimap5 deficiency results in a decrease of m, indicating 
impaired integrity of mitochondria.
In addition, the in vitro BrdU labeling assay demonstrated 
that cytokine-mediated cell proliferation was comparable be-
tween Gimap5-deficient and wild-type B cell and hematopoi-
etic progenitors (Fig. 6, H and I). Consistent with the findings 
that Gimap5 deficiency reduced Mcl-1 stability, Annexin V 
and 7-AAD staining assay detected that cytokine withdrawal–
induced cell apoptosis was markedly enhanced in Gimap5-
deficient relative to wild-type primary B cell or hematopoietic 
progenitors (Fig. 6, J and K). Therefore, Gimap5 deficiency 
increases cytokine withdrawal–induced cell apoptosis of B cell 
and hematopoietic progenitors. It is of note that expression 
of Gimap5, but not GFP alone, by retrovirus-mediated gene 
transfer restored the survival of BM-derived Gimap5-deficient 
hematopoietic progenitors to the same level as was observed 
in wild-type hematopoietic progenitors transduced with GFP 
alone (Fig. S3). Expression of Flag-tagged Gimap5 restored 
the survival of BM-derived Gimap5-deficient hematopoi-
etic progenitors to the same extent as wild-type Gimap5 
(Fig. S3). Collectively, these data demonstrate that Gimap5 
deficiency impairs the interaction between Mcl-1 and HSC70, 
decreases the stability of Mcl-1, and reduces the integrity of 
mitochondria, resulting in an increase of cell apoptosis.
DISCUSSION
Previous studies have demonstrated that Gimap5 is essential 
for the survival and development of T lymphocytes, including 
T reg cells, and its mutation leads to T lymphopenia in rat and 
mouse (Plamondon et al., 1990; Groen et al., 1995; Iwakoshi 
et al., 1998; Hernández-Hoyos et al., 1999; Whalen et al., 
1999;  Hornum  et  al.,  2002;  MacMurray  et  al.,  2002;   
Pandarpurkar et al., 2003; Michalkiewicz et al., 2004; Poussier   
et al., 2005; Nitta et al., 2006; Schulteis et al., 2008). However, 
the consequences of Gimap5 deficiency in the mouse are not 
limited to T cell defects but extend to defective development 
of B cells and NK cells (Schulteis et al., 2008). All these   
abnormalities in the Gimap5-deficient mouse are confirmed in 
the sphinx mouse strain, which exhibits a loss of Gimap5 protein 
Gimap5 deficiency markedly reduced the amount of endoge-
nous HSC70 that was coimmunoprecipitated with endogenous 
Bcl-2 (unpublished data). It is of note that both wild-type and 
mutant cells expressed the same amount of HSC70 proteins 
(Fig. 6 B). Thus, Gimap5 is required for the firm interaction 
between Mcl-1 or Bcl-xL and HSC-70.
We next examined the effect of Gimap5 deficiency on 
the cellular localization of Mcl-1 or Bcl-xL and HSC-70. 
Subcellular fractionation analysis demonstrated that endoge-
nous Gimap5 exclusively localized in mitochondria-rich 
fraction in wild-type but was absent in Gimap5-deficient 
BM-derived primary B cell progenitors (Fig. 6 C). It is of 
note that the cellular localization of Mcl-1 and Bcl-xL was 
the same in wild-type and Gimap5-deficient primary B cell 
progenitors (Fig. 6 C). Similarly, the cellular localization of 
HSC70 was also the same in both wild-type and Gimap5- 
deficient primary B cell progenitors (Fig. 6 C). Furthermore, 
exclusive mitochondria localization of endogenous Gimap5 
was observed in wild-type BM-derived hematopoietic pro-
genitors (Fig. 6 D). Again, the cellular localization of Mcl-1, 
Bcl-xL, Bcl-2, and HSC70 was the same in wild-type and 
Gimap5-deficient hematopoietic progenitors (Fig. 6 D). Thus, 
Gimap5 deficiency does not affect cellular localization, in-
cluding mitochondrial localization, of Mcl-1, Bcl-xL, Bcl-2, 
and HSC70.
Mcl-1  is  eliminated  by  proteasome-dependent  protein 
degradation and withdrawal of cytokines can trigger Mcl-1 
elimination (Zhong et al., 2005; Maurer et al., 2006). Previous 
studies have shown that Mcl-1 and Bcl-xL associate with 
HSP70,  which  stabilizes  Mcl-1  and  Bcl-xL  (Jacobs  and 
Marnett, 2007, 2009; Stankiewicz et al., 2009). To this end,   
we examined the effect of Gimap5 deficiency on the stabilities 
of Mcl-1 and Bcl-xL. As expected, withdrawal of IL-7 prompted 
Mcl-1 degradation in wild-type primary B cell progenitors 
(Fig. 6 E). Importantly, the levels of Mcl-1 protein subsequent 
to IL-7 withdrawal were markedly lower in Gimap5-deficient 
relative to wild-type primary B cell progenitors (Fig. 6 E). In 
contrast, the levels of Bcl-xL and Bax proteins were largely 
stable after IL-7 withdrawal in both wild-type and Gimap5-
deficient progenitors (Fig. 6 E). It is of note that IL-7 with-
drawal also accelerated Bcl-2 degradation in Gimap5-deficient 
relative to wild-type primary B cell progenitors (Fig. 6 E). 
Therefore,  Gimap5  deficiency  reduced  the  stabilities  of 
Mcl-1 and Bcl-2, but not Bcl-xL or Bax, in B cell progenitors. 
Furthermore, we examined the effect of Gimap5 deficiency 
on the stabilities of Bcl-2 family members in BM-derived he-
matopoietic progenitors. Withdrawal of cytokines (IL-3, IL-6, 
and SCF) accelerated Mcl-1 degradation in Gimap5-deficient 
relative to wild-type hematopoietic progenitors (Fig. 6 F). 
Cytokine withdrawal induced Bcl-xL degradation in wild-
type hematopoietic progenitors, but lack of Gimap5 did not 
influence this process (Fig. 6 F). It is of note that the levels of 
Bcl-2 proteins were stable after cytokine withdrawal in both 
wild-type  and  Gimap5-deficient  progenitors  (Fig.  6  F). 
Therefore, Gimap5 deficiency reduced the stabilities of Mcl-1, 
but not Bcl-xL or Bcl-2, in hematopoietic progenitors.JEM VOL. 208, May 9, 2011 
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by proteasome-dependent protein degradation (Zhong et al., 
2005; Maurer et al., 2006). With a loss of Gimap5, cytokine 
withdrawal–induced degradation of Mcl-1 is markedly en-
hanced. Gimap5-deficient hematopoietic cells are more prone 
to apoptosis than wild-type corresponding cells, especially 
when cytokines are limiting. Consequently, Gimap5-deficient 
hematopoietic progenitors, including HSCs, fail to compete 
with wild-type counterparts in competitive engraftment. The 
Gimap5 deficiency–induced loss of the cellularity of all he-
matopoietic lineages becomes more pronounced with age. A 
nearly complete loss of B cell populations and an associated 
increase in apoptotic cells in the BM of aged Gimap5-deficient 
mice (unpublished data) is consistent with progressive deple-
tion of HSCs in these mutant mice. In contrast, overexpres-
sion of Gimap5 might confer hematopoietic cells a survival 
advantage and resistance to cytokine insufficiency–induced 
cell death. In fact, Gimap5 is up-regulated in human B cell 
lymphomas, indicating that a gain of Gimap5 function might 
contribute to the development of B cell malignancy by inhib-
iting cell apoptosis (Zenz et al., 2004).
Our current studies and several of the previous studies 
have demonstrated that Gimap5 predominantly localizes on 
mitochondria (Dahéron et al., 2001; Hornum et al., 2002; 
Pandarpurkar et al., 2003; Zenz et al., 2004; Keita et al., 2007), 
although some other studies have indicated that Gimap5 is 
also expressed on ER membrane (Stamm et al., 2002). Lack 
of Gimap5 in rat T cells alters the composition of mitochon-
drial membrane protein complexes, resulting in loss of mito-
chondrial  integrity  and  increased  spontaneous  apoptosis 
(Pandarpurkar et al., 2003). A hairpin RNA–mediated Gimap5 
knockdown induces the mitochondria-mediated apoptosis in 
a  T cell line (Nitta et al., 2006). A previous study has detected 
the interaction between Gimap5 and Bcl-2 when these mol-
ecules are overexpressed in T cell line (Nitta et al., 2006). The 
same study has also found the association between Gimap5 
and Bcl-xL when they are overexpressed in T cell line (Nitta 
et al., 2006). In addition, Bax, a proapoptotic member of Bcl-2 
family, has been shown to associate with Gimap5 after its 
apoptosis-induced  translocation  onto  mitochondrial  mem-
brane (Nitta et al., 2006). Thus, the association between the 
Gimap family proteins and the Bcl-2 family proteins might be 
the key to maintaining the integrity of mitochondrial mem-
brane. However, the mechanism by which Gimap5 maintains 
mitochondrial integrity through the association with the Bcl-2 
family proteins has been unclear. In this study, we have discov-
ered that Gimap5 physically interacts not only with Bcl-xL 
and Bcl-2 but also with Mcl-1 and HSC70, a member of the 
Hsp70 family. Thus, Gimap5 appears to strengthen the associa-
tion between Mcl-1/Bcl-xL/Bcl-2 and HSC70 on mitochon-
dria. It is of note that removal of Mcl-1 is regulated by 
proteasome-dependent protein degradation, and this elimina-
tion of Mcl-1 is associated with mitochondria-mediated cell 
apoptosis (Zhong et al., 2005). Previous studies have found that 
HSP70 associates with Mcl-1 and, thus, prevents it from ubiqui-
tination and subsequent degradation (Stankiewicz et al., 2009). 
Importantly, our findings have demonstrated that HSC70 may 
expression  secondary  to  ENU-induced  mutagenesis  (Barnes   
et al., 2010). In addition, excessive hematopoiesis in the liver, 
and to a lesser extent in the spleen, is a phenotypic hallmark 
of mice lacking Gimap5 (Schulteis et al., 2008; Barnes et al., 
2010). A markedly increased number of hepatic hematopoi-
etic foci can already be detected in 3-wk-old Gimap5- 
deficient mice and becomes progressively dominant in older 
mice (12–15 wk; Schulteis et al., 2008). Although extramedullary 
hematopoiesis is usually considered a compensatory response 
to reduced BM output or outright failure, no such defects in 
marrow cellularity or cellular composition were detected in 
relative young Gimap5-deficient mice with mixed genetic 
background (C57BL/6 and 129; Schulteis et al., 2008; Barnes 
et al., 2010). In this paper, we demonstrate that Gimap5 is   
expressed in HSCs, hematopoietic progenitors, and differenti-
ated blood cells and is critical for their survival. Gimap5 
deficiency  results  in  reduction  in  primitive  hematopoietic 
progenitors and multiple hematopoietic lineages. The reduc-
tion of committed progenitors and differentiated cells leads   
to a breakdown of quiescence of Gimap5-deficient HSCs. In 
addition, Gimap5-deficient HSCs have impaired engrafting 
ability. Gimap5-deficient HSCs, hematopoietic progenitors, 
and differentiated blood cells all have increased apoptosis.
Members of the Bcl-2 family play important and unique 
roles during hematopoiesis. Mcl-1 is essential for the survival 
of HSCs and other early hematopoietic progenitors (Opferman 
et al., 2005). Inducible deletion of Mcl-1 in mice results in the 
loss of HSCs and other hematopoietic progenitors (Opferman 
et al., 2005). Mcl-1 also plays an important role in the main-
tenance of the mature lymphocytes (Opferman et al., 2003). 
Bcl-2 is critical for the survival of mature lymphocytes but 
not for early hematopoiesis (Veis et al., 1993). Loss of Bcl-2 
leads to massive apoptosis of T and B lymphocytes (Veis et al., 
1993). Bcl-xL is important for survival of erythrocytes and   
T cells, and Bcl-xL–deficient mice display a massive loss of im-
mature erythrocytes and double-positive early T cells (Ma et al., 
1995; Motoyama et al., 1995, 1999). Proapoptotic Bim is crit-
ical for the survival of hematopoietic progenitors, and its de-
ficiency results in an increase of myeloid and lymphoid but 
not erythroid cells (Bouillet et al., 1999). In addition, the pro-
apoptotic family members Puma and Nix are implicated in 
regulating the survival of lymphocytes and erythrocytes, re-
spectively (Erlacher et al., 2006; Diwan et al., 2007). Impor-
tantly, Gimap5 plays a critical role in stabilizing Mcl-1 in 
BM-derived hematopoietic progenitors. Thus, Gimap5 regu-
lates the survival of HSCs and other early hematopoietic pro-
genitors at least partially through stabilizing Mcl-1. In addition 
to Mcl-1, Gimap5 can stabilize Bcl-2 in BM-derived B cell 
progenitors. Accordingly, destabilization of both Mcl-1 and 
Bcl-2 proteins by Gimap5 deficiency may explain the more 
severe reduction and obvious loss of viability in mature lym-
phoid lineages relative to early hematopoietic progenitors and 
myeloid lineages in Gimap5-deficient mice.
Mcl-1 expression is up-regulated by SCF stimulation in 
HSCs and by IL-7 in lymphoid progenitors (Opferman et al., 
2003, 2005). Withdrawal of cytokines triggers Mcl-1 elimination 932 Gimap5 in HSC survival and quiescence | Chen et al.
Resource Center at the Medical College of Wisconsin (MCW). All animal 
protocols were approved by the MCW Institutional Animal Care and   
Use Committee.
Real-time quantitative RT-PCR analysis. Subsets of hematopoietic pro-
genitors and differentiated cells were sorted from BM cells of 2-mo-old 
wild-type mice by flow cytometry. Total RNA was isolated from the indi-
cated cells. First-strand cDNA was synthesized from the total RNA with the 
Sensiscript RT kit (QIAGEN) using random primers (Invitrogen) according 
to the manufacturer’s protocol. Real-time PCR was performed to quantitate 
Gimap5 using the following primers: 5 primer, 5-GCTGACAGCCGC-
TTGG-3; and 3 primer, 5-TGGGCTTCTGGTCCTTGAAC-3. Levels 
of Gimap5 transcription were normalized to -actin abundance. The primers 
used for -actin were: 5 primer, 5-CCACAGCTGAGAGGGAAATC-3; 
and 3 primer, 5-CTTCTCCAGGGAGGAAGAGG-3. Real-time PCR 
was performed in triplicate at 50°C for 2 min and then 95°C for 10 min, fol-
lowed by 40 cycles of 95°C for 15 s and 60°C for 1 min using the 7500 
Real-Time system (Applied Biosystems) in 25-µl reaction volumes contain-
ing cDNA, primers, and iQ SYBR Green Supermix (Bio-Rad Laboratories). 
Data were analyzed using the 7500 system analyzing software and relative 
transcription was calculated using the Ct method.
Flow cytometry. Single-cell suspensions of BM cells were treated with 
Gey’s solution to remove red blood cells and resuspended in PBS supple-
mented with 2% FBS. The cells were then stained with a combination of   
fluorescence-conjugated antibodies. PE-conjugated anti–Mac-1, anti-B220, 
anti–Gr-1, anti–Ter-119, anti–c-Kit, anti-FcR, and anti-FoxP3; FITC- 
conjugated anti-CD34, anti-CD71, Sca-1, and anti-CD150; Biotin-conjugated 
anti-CD4, anti-CD8, anti-Ter119, and anti-CD135; APC-conjugated anti-B220, 
anti–c-Kit, anti–Mac-1, and anti-IgM; PE-Cy5–conjugated anti-CD80;   
PE-Cy7–conjugated anti-CD69 and anti-B220; and PE-Cy5.5–conjugated anti- 
streptavidin were purchased from eBioscience. PE-conjugated anti-Thy1.2, 
anti-CD4, anti-CD8, and anti-CD86; Biotin-conjugated anti–Gr-1, anti–
Mac-1,  anti-B220,  and  anti–IL-7R;  and  FITC-conjugated  anti-CD45.2, 
anti-BrdU, and anti–Annexin V were purchased from BD. DAPI was added 
after staining to exclude the dead cells. Samples were applied to a flow cyto-
meter (LSRII; BD). Data were collected and analyzed using CellQuest or 
FACSDiva software (BD).
In vivo and in vitro BrdU incorporation assay. Mice were intraperito-
nealy injected with 1 mg BrdU (Sigma-Aldrich) in 0.2 ml PBS 2 h before analy-
ses. The BM cells from BrdU-injected mice were incubated with Bio-conjugated 
CD135, followed by staining with the combination of PE-conjugated lineage 
cocktail (anti–Mac-1, Gr-1, B220, CD4, CD8, Ter-119, and IL-7R), PE-cy7–
conjugated anti–Sca-1, APC-conjugated anti-c-Kit, and PE-Cy5.5–conjugated 
streptavidin. Finally, the cells were fixed and then stained with FITC-conjugated 
anti-BrdU and DAPI. For in vitro BrdU incorporation, IL-7 BM culture– 
derived B cell or IL-3 + IL-6 + SCF BM culture–derived hematopoietic 
progenitors were cultured in the presence of 10 µM BrdU for 1 h. Then,   
B cell progenitors were stained with APC-conjugated anti-B220, FITC-
conjugated anti-BrdU, and 7-AAD, whereas hematopoietic progenitors were 
stained with lineage cocktail, anti-BrdU, and DAPI. The degree of BrdU 
positivity was analyzed by FACS.
Cell apoptosis assay. The BM cells from wild-type and Gimap5-deficient 
mice were stained with the combination of PE-conjugated lineage cocktail 
(Mac-1, Gr-1, B220, CD4, CD8, Ter-119, and IL-7R), PE-Cy7–conjugated 
Sca-1, and APC-conjugated anti–c-Kit, followed by staining with FITC-
conjugated Annexin  V and DAPI. The degree of Annexin  V+DAPI apoptotic 
cells in the different gated hematopoietic subpopulations was analyzed by 
FACS. For the detection of cytokine withdrawal-induced cell apoptosis, IL-7 
BM culture–derived B cell or IL-3 + IL-6 + SCF BM culture–derived   
hematopoietic progenitors were cultured in the absence of cytokines for the 
indicated times, followed by the staining with APC-conjugated Annexin V 
and 7-AAD. The degree of Annexin V+ cells was analyzed by FACS.
not directly associate with Mcl-1, and Gimap5 is required to 
connect HSC70 and Mcl-1 together to form the HSC70–
Gimap5–Mcl-1 ternary complex. Lack of Gimap5 impairs 
the association of HSC70 with Mcl-1, resulting in a rapid 
degradation of Mcl-1 and subsequent cell apoptosis. It is of 
note that Gimap5 deficiency has no effect on Mcl-1 mito-
chondrial  localization.  In  addition,  HSC70  associates  with 
Bcl-xL and Bcl-2 and prevents them from degradation (Jacobs 
and Marnett, 2007, 2009). We have found that Gimap5 mark-
edly strengthens the association of HSC70 with Bcl-xL and 
Bcl-2. However, lack of Gimap5 impairs the association of 
HSC70 with Bcl-xL and Bcl-2 but only results in a rapid 
degradation of Bcl-2 in B cells. Again, Gimap5 deficiency has 
no effect on the cellular localization of Bcl-xL and Bcl-2. 
Gimap5 specifically stabilizes Mcl-1 and Bcl-2 but not Bcl-xL, 
indicating that an additional mechanism is involved in regu-
lating Bcl-xL stabilization. Bcl-2 family members play a critical 
role in maintaining mitochondrial outer membrane integrity 
(Newmeyer and Ferguson-Miller, 2003; Green, 2005). Thus, 
Gimap5 maintains mitochondrial integrity and subsequent 
cell viability through stabilization but not mitochondrial   
localization of Mcl-1 and Bcl-2. A limitation of the current 
analysis is that all of the biochemical studies were performed 
in cell lines and in vitro BM culture–derived hematopoietic 
or B cell progenitors. Regulation of survival of these cells in 
vitro may not be exactly same as that of HSCs or hematopoi-
etic progenitors in vivo. Stabilization of Mcl-1 by Gimap5 via 
HSC70 should be further evaluated in rare primary hemato-
poietic progenitors and HSCs when new technique permits.
The structural basis of Gimap5 function is still unresolved. 
Gimap5 has a putative GTP-binding domain (amino acids 
30–84) at the N terminus (Sandal et al., 2003), but the rele-
vance of GTP-binding activity in Gimap5 for its antiapop-
totic function is currently uncertain. An N-terminal deletion 
mutant of Gimap5 lacking the putative GTP-binding domain 
retains full antiapoptotic activity (Sandal et al., 2003). Gimap5 
has a putative transmembrane domain (amino acids 281–304) 
at the C terminus, but the C-terminal truncation mutant 
lacking the putative transmembrane domain also possesses full 
antiapoptotic activity (Sandal et al., 2003). Moreover, expres-
sion of a small fragment of Gimap5 (amino acids 235–285) 
exhibits the same specific antiapoptotic activity against apop-
totic inducer okadaic acid as full-length Gimap5 in Jurkat 
cells (Sandal et al., 2001). Thus, the region spanning amino 
acids 235–285 seems to possess all the required functional 
elements for conferring Gimap5’s antiapoptotic function. A   
detailed study of the structural basis for the intracellular inter-
action between Gimap5 and HSC70, as well as Mcl-1–Bcl-2, 
would shed more light on the molecular mechanisms of 
Gimap5-mediated stabilization of Mcl-1 and Bcl-2, as well as 
Gimap5-mediated cell apoptosis in hematopoiesis.
MATERIALS AND METHODS
Mice.  Gimap5-deficient  mice  were  generated  as  previously  reported 
(Schulteis et al., 2008) and were on the C57BL/6 background. Experimental 
and control mice were 9–14 wk old. Mice were maintained in the Biological JEM VOL. 208, May 9, 2011 
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Immunofluorescence microscopy. 70Z/3 cells that stably express Flag-
tagged Gimap5 were washed twice in PBS, resuspended in PBS (5 × 106 
cells/ml), and applied to glass slides in 10-µl aliquots. After cells completely   
dried, the slides were fixed for 30 min in 4% buffered formalin (Thermo Fisher 
Scientific), permeabilized by incubation in 0.2% Triton X-100 in PBS for   
15 min, and blocked for 1 h at room temperature with 10% bovine serum al-
bumin in PBS. After blocking, the slides were incubated for 2 h at room tem-
perature with mouse anti-Flag with a combination of rabbit anti–Mcl-1 
(Rockland Immunochemicals), or rat anti-HSC70 (Santa Cruz Biotechnol-
ogy, Inc.), respectively. Slides were washed three times in PBS and incubated 
for additional 1 h at room temperature with PE-conjugated goat anti–rabbit 
IgG (SouthernBiotech), APC-conjugated goat anti–mouse IgG1 (BD), or 
donkey anti–rat IgG (eBioscience), respectively. Slides were then washed 
three times with PBS, mounted with Vectashield (Vector Laboratories), and 
examined for fluorescence using a confocal microscope (FlowView mul-
tiphoton  LSM;  Olympus).  Images  were  obtained  and  processed  using 
FlowView software.
BM homing assay. BM homing assay was performed as previously de-
scribed (Cheng et al., 2000; Maillard et al., 2009). In brief, 2 × 107 BM cells 
from wild-type or Gimap5-deficient mice were intravenously injected into 
lethally irradiated (1,100 rads) CD45.1+ B6-SJL recipients. 6 h later, the per-
centage of CD45.2+Lin donor hematopoietic progenitors in the recipient 
BM was determined by FACS.
Online supplemental material. Fig. S1 shows the engrafting capacity of 
Gimap5-deficient hematopoietic progenitors. Fig. S2 shows the T reg cell 
population and lymphocyte activation status in competitively reconstituted 
recipients. Fig. S3 describes the rescue of Gimap5-deficienct hematopoietic 
progenitors from cytokine withdrawal-induced apoptosis by the expression 
of wild-type or Flag-tagged Gimap5. Online supplemental material is avail-
able at http://www.jem.org/cgi/content/full/jem.20101192/DC1.
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